Related Experiment Video
Updated: May 10, 2026
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Autologous serum therapy in chronic urticaria
Sharmila Patil1, Nidhi Sharma, Kiran Godse
1Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Nerul, Navi Mumbai, India.
Indian Journal of Dermatology
|June 1, 2013
Summary
Autologous serum therapy offers a promising and economical treatment for persistent urticaria, particularly in developing nations. This method requires minimal equipment, making it accessible for widespread use.
Area of Science:
- Dermatology
- Immunology
Background:
- Urticaria is a common skin condition.
- Treatment-resistant urticaria poses a clinical challenge.
- Autologous serum therapy is an emerging treatment option.
Purpose of the Study:
- To evaluate the efficacy of autologous serum therapy for treatment-resistant urticaria.
- To highlight the economic viability of autologous serum therapy in developing countries.
Main Methods:
- Autologous serum therapy involves injecting a patient's own serum intradermally.
- Minimal equipment, including a centrifuge, syringe, and needles, is required.
Main Results:
- Autologous serum therapy shows promise for managing recalcitrant urticaria.
- The procedure is cost-effective and requires basic medical instruments.
Conclusions:
- Autologous serum therapy is a viable and economical treatment for resistant urticaria.
- Its simplicity makes it suitable for resource-limited settings.
